FRAZIER MANAGEMENT LLC
SEATTLE, WA · CIK 1032165 · 13F filing filed 2021-05-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityFRAZIER MANAGEMENT, L.L.C. (US)
- Others nearbySeattle, WA
As an employer
US visa salary filings
- Filings FY20251
- Median salary offered$125,000
- Middle half$125,000 – $125,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Associate, Investment AnalystSeattle, WA | 1 | $125,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Frazier Management LLC.
$1.2bn
reported value
-4.0% vs Q4 2020
35positions
77.8%in top 10
4 new
7 added
2 reduced
4 sold out
vs Q4 2020
Holdings, Q1 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $305.0m24.46% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $218.9m17.56% | Unchanged |
| PASSAGE BIO INC COM | $87.6m7.02% | Unchanged |
| MIRUM PHARMACEUTICALS INC MIRM | $70.7m5.67% | Unchanged |
| KRYSTAL BIOTECH INC KRYS | $69.0m5.53% | Unchanged |
| TARSUS PHARMACEUTICALS INC TARS | $61.8m4.96% | Unchanged |
| VAXCYTE INC PCVX | $45.6m3.66% | Unchanged |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $41.6m3.33% | Unchanged |
| TRANSLATE BIO INC COM | $36.0m2.89% | Unchanged |
| TRILLIUM THERAPEUTICS INC TR | $33.4m2.68% | Added +70.0k |
| SYNDAX PHARMACEUTICALS INC SNDX | $32.1m2.57% | Added +30.0k |
| ALPINE IMMUNE SCIENCES INC NVLS | $27.3m2.19% | Unchanged |
| SUTRO BIOPHARMA INC COM | $22.8m1.83% | Unchanged |
| ANAPTYSBIO INC ANAB | $19.4m1.56% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $17.5m1.41% | New |
| MOLECULAR TEMPLATES INC COM | $17.3m1.39% | Added +532.1k |
| IVERIC BIO INC OPHT | $15.7m1.26% | Added +50.0k |
| FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 | $15.2m1.22% | Unchanged |
| ADVERUM BIOTECHNOLOGIES INC COM | $14.2m1.14% | Unchanged |
| REGENXBIO INC RGNX | $12.0m0.96% | Added +10.0k |
| GRITSTONE BIO INC GRTS | $9.7m0.78% | Reduced -1.0m |
| APTINYX INC COM | $9.6m0.77% | Unchanged |
| ESSA PHARMA INC EPI | $9.2m0.74% | New |
| IMMUNOVANT INC IMVT | $8.1m0.65% | New |
| SCHOLAR ROCK HLDG CORP SRRK | $7.9m0.63% | Added +2.5k |
| FREELINE THERAPEUTICS HLDGS SPONSORED ADS | $6.8m0.54% | Unchanged |
| EPIZYME INC EPZM | $6.4m0.52% | Added +7.9k |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $5.2m0.42% | New |
| BELLUS HEALTH INC NEW BLU | $4.9m0.40% | Unchanged |
| ALLENA PHARMACEUTICALS ALNA | $4.6m0.37% | Unchanged |
| SIERRA ONCOLOGY INC COM NEW | $3.5m0.28% | Unchanged |
| CARDIFF ONCOLOGY INC CRDF | $2.7m0.22% | Reduced -275.0k |
| ITERUM THERAPEUTICS PLC ITRMF | $2.2m0.17% | Unchanged |
| GALERA THERAPEUTICS INC COM | $2.1m0.17% | Unchanged |
| NABRIVA THERAPEUTICS PLC SHS | $707.0k0.06% | Unchanged |
Sold out since Q4 2020
| Security | Value then |
|---|---|
| COLLEGIUM PHARMACEUTICAL INC COLL | $18.9m943.7k shares |
| ROCKET PHARMACEUTICALS INC RCKT | $9.2m168.0k shares |
| ARS PHARMACEUTICALS INC SPRY | $1.7m35.8k shares |
| MINERVA NEUROSCIENCES INC NERV | $144.0k61.5k shares |